1. Home
  2. DOUG vs STXS Comparison

DOUG vs STXS Comparison

Compare DOUG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Elliman Inc.

DOUG

Douglas Elliman Inc.

HOLD

Current Price

$1.81

Market Cap

178.2M

Sector

Real Estate

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.40

Market Cap

164.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOUG
STXS
Founded
1911
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.2M
164.1M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
DOUG
STXS
Price
$1.81
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
409.6K
530.7K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
118.68
16.67
EPS
N/A
N/A
Revenue
$955,578,000.00
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$1.24
52 Week High
$3.19
$3.59

Technical Indicators

Market Signals
Indicator
DOUG
STXS
Relative Strength Index (RSI) 45.95 45.56
Support Level $1.68 $1.30
Resistance Level $1.84 $1.51
Average True Range (ATR) 0.07 0.06
MACD -0.02 0.01
Stochastic Oscillator 21.43 28.12

Price Performance

Historical Comparison
DOUG
STXS

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: